194 related articles for article (PubMed ID: 11763499)
1. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
Hammond SA; Guebre-Xabier M; Yu J; Glenn GM
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):503-26. PubMed ID: 11763499
[TBL] [Abstract][Full Text] [Related]
2. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
Tezel A; Paliwal S; Shen Z; Mitragotri S
Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
[TBL] [Abstract][Full Text] [Related]
3. Initiation of adaptive immune responses by transcutaneous immunization.
Warger T; Schild H; Rechtsteiner G
Immunol Lett; 2007 Mar; 109(1):13-20. PubMed ID: 17320194
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
[TBL] [Abstract][Full Text] [Related]
5. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
[TBL] [Abstract][Full Text] [Related]
6. [Skin vaccination].
Naito S
Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous immunization with Intercell's vaccine delivery system.
Seid RC; Look JL; Ruiz C; Frolov V; Flyer D; Schafer J; Ellingsworth L
Vaccine; 2012 Jun; 30(29):4349-54. PubMed ID: 22682290
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous immunization using common chemicals.
Karande P; Arora A; Pham TK; Stevens D; Wojicki A; Mitragotri S
J Control Release; 2009 Sep; 138(2):134-40. PubMed ID: 19426770
[TBL] [Abstract][Full Text] [Related]
11. Particle-based vaccines for transcutaneous vaccination.
Combadière B; Mahé B
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):293-315. PubMed ID: 17915323
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies.
Karande P; Mitragotri S
Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578
[TBL] [Abstract][Full Text] [Related]
13. Development of novel fusogenic vesosomes for transcutaneous immunization.
Mishra V; Mahor S; Rawat A; Dubey P; Gupta PN; Singh P; Vyas SP
Vaccine; 2006 Jul; 24(27-28):5559-70. PubMed ID: 16730102
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
Skountzou I; Quan FS; Jacob J; Compans RW; Kang SM
Vaccine; 2006 Aug; 24(35-36):6110-9. PubMed ID: 16766095
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous immunization and immunostimulant strategies.
Glenn GM; Kenney RT; Hammond SA; Ellingsworth LR
Immunol Allergy Clin North Am; 2003 Nov; 23(4):787-813. PubMed ID: 14753392
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous and intradermal vaccination.
Combadiere B; Liard C
Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection.
Cheng JY; Huang HN; Tseng WC; Li TL; Chan YL; Cheng KC; Wu CJ
J Control Release; 2009 May; 135(3):242-9. PubMed ID: 19331858
[TBL] [Abstract][Full Text] [Related]
19. Targeting epidermal Langerhans cells by epidermal powder immunization.
Chen D; Payne LG
Cell Res; 2002 Jun; 12(2):97-104. PubMed ID: 12118944
[TBL] [Abstract][Full Text] [Related]
20. Modulation of immune responses with transcutaneously deliverable adjuvants.
Partidos CD; Beignon AS; Briand JP; Muller S
Vaccine; 2004 Jun; 22(19):2385-90. PubMed ID: 15193399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
